(Total Views: 544)
Posted On: 08/02/2023 4:53:23 PM
Post# of 22461
Do YOU remember the video YOU were though only an insider could find where DR Fraser shared a Long COVID test prototype he developed with QMC Health.
The same Dr Fraser who sold QMC the Biomarkers for COVID and developed the biomarkers for TBI diseases for QMC partner Neurolytixs.
The same Dr Fraser who sold QMC the Biomarkers for COVID and developed the biomarkers for TBI diseases for QMC partner Neurolytixs.
Quote:
Neurolytixs’ ground-breaking technology is revolutionizing concussion diagnosis. Our proprietary research has identified a number of blood biomarkers that accurately identify brain injury among patients. Developed by Dr. Doug Fraser, a professor, clinician scientist, and Fellow of the Royal College of Physicians and Surgeons of Canada, this technology is the first test of its kind to yield accuracy in concussion diagnosis.
(0)
(0)Scroll down for more posts ▼
